Data / Form D filings / Zenas BioPharma, Inc.
Zenas BioPharma, Inc.: Form D filings
Zenas BioPharma, Inc., a biotechnology company in Waltham, MA, filed 2 Form D notices with the SEC between 2022 and 2024. The latest, on May 14, 2024, reports $200.1 million sold of a $200.1 million offering to 26 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1000 WINTER ST, SUITE 1200, Waltham, MA, 02451
- Phone
- (857) 271-2954
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1953926
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 14, 2024 | New notice | $200,145,732 | $200,145,732 | 26 | May 3, 2024 | sec.gov | |
| Nov 15, 2022 | New notice | $183,898,435 | $183,898,435 | 17 | Nov 2, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| PATRICK GERALD ENRIGHT | Director | |
| TOMAS O. KISELAK | Director | |
| PATRICIA JACOB ALLEN | Director | |
| JOSEPH O. FARMER | Executive Officer | |
| LEON O. MOULDER, JR. | Executive Officer, Director | |
| JAKE JACOB NUNN | Director | |
| TIM JACOB XIAO | Director | |
| JENNIFER JACOB FOX | Executive Officer | |
| JAMES PATRICK BOYLAN | Director | |
| TANYA Z. FISCHER | Executive Officer | |
| JOHN JACOB ORLOFF | Director | |
| HONGBO O. LU | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of May 13, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Zenas BioPharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.